EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparison of disease risk score methods to study treatment effect heterogeneity: a simulation study

Haedi E Thelen iD, Wei Yang iD, Sean Hennessy iD, Jordana Cohen iD, Wensheng Guo iD, Todd A Miano iD

American Journal of Epidemiology · 08.07.2026 · 195 (7) · 2037-2045

DOI: 10.1093/aje/kwag050 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift American Journal of Epidemiology, online erschienen am 06.03.2026. Verfasst von Haedi E Thelen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, United States. Hauptthemen laut MEDLINE: Treatment Effect Heterogeneity, Randomized Controlled Trials as Topic, Models, Statistical. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estimating treatment effects across disease risk scores (DRSs) is a common approach for assessing treatment effect heterogeneity in randomized trials. When external models are unavailable, the optimal approach for internally fitting the DRS model remains uncertain. This simulation study compares 3 internal derivation approaches, evaluating bias of estimated treatment effects within DRS-defined strata. We simulated trials under varying treatment effects (odds ratios [OR] of 1, 0.8, and 0.5) and treatment–covariate interactions. We fit DRS models on (1) a controls-only method, (2) the full sample ignoring treatment assignment, and (3) a random split-sample method of 50% of the controls, who were removed from the second stage of analysis. Additional simulations varied outcome incidence, sample size, randomization ratio, and the true DRS C-statistic. Bias decreased with the split-sample method (overall percent bias [OPB] 7.7% for OR = 0.8 with interactions) compared to the controls-only (OPB = 15.6%) and full-sample methods (OPB = 22.1%). Bias decreased more with the split-sample method than with controls-only and full-sample methods with larger sample sizes, higher outcome incidence, greater treated-to-control ratios, and larger C-statistics. These findings suggest split-sample methods may be the preferred approach to estimate treatment effect heterogeneity by the DRS in trials with sufficient data to support stable prediction modeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Treatment Effect HeterogeneityRandomized Controlled Trials as TopicModels, StatisticalHumansComputer SimulationRisk AssessmentBiasSample Size

Stichwörter der Autor:innen

clinical prediction modelsclinical trialeffect modificationrisk predictiontreatment effect heterogeneity

Autor:innen und Institutionen

  • Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, United States.
  • Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania, Philadelphia, PA, United States.
  • Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, United States.

ORCID-Profile: Haedi E Thelen, Wei Yang, Sean Hennessy, Jordana Cohen, Wensheng Guo, Todd A Miano

Förderung

  • NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health

Zitieren

APA

Thelen, H. E., Yang, W., Hennessy, S., Cohen, J., Guo, W., & Miano, T. A. (2026). Comparison of disease risk score methods to study treatment effect heterogeneity: a simulation study. American Journal of Epidemiology, 195(7), 2037-2045. https://doi.org/10.1093/aje/kwag050

Vancouver

Thelen HE, Yang W, Hennessy S, Cohen J, Guo W, Miano TA. Comparison of disease risk score methods to study treatment effect heterogeneity: a simulation study. American Journal of Epidemiology. 2026;195(7):2037-2045. doi:10.1093/aje/kwag050

BibTeX
@article{Thelen2026,
  author = {Thelen, Haedi E and Yang, Wei and Hennessy, Sean and Cohen, Jordana and Guo, Wensheng and Miano, Todd A},
  title = {Comparison of disease risk score methods to study treatment effect heterogeneity: a simulation study},
  journal = {American Journal of Epidemiology},
  year = {2026},
  volume = {195},
  number = {7},
  pages = {2037--2045},
  doi = {10.1093/aje/kwag050}
}
Kostenlos starten →